Data Characteristics for This Category
Bioequivalence clinical trial data primarily comes from public databases of the National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE), clinical trial registration platforms, and internal reports from pharmaceutical research and development companies. Data update frequency is relatively stable, typically released periodically after drug review or filing. Document structures mainly include research reports, clinical protocols, and statistical analysis reports. Content covers subject demographics, drug plasma concentration-time curves (AUC, Cmax), adverse event records, and statistical analysis results. Fields include subject ID, dosage, blood sampling time points, plasma concentration (units: ng/mL or μg/mL), and Tmax (units: hours). Documents are usually in PDF format, containing numerous tables and charts.
Constraints Imposed by These Characteristics on Multi-turn Conversations and Prompts
The complexity of bioequivalence data requires precise understanding of user intent during multi-turn conversations to avoid misinterpretations due to ambiguous terminology. For example, a query for "Cmax" may require distinguishing between peak concentrations for single-dose and steady-state administration. Extracting tabular data from PDF documents is a core challenge, requiring accurate identification of data fields and correct unit conversion. Additionally, due to periodic data updates, prompt design needs to guide users to specify data timeliness requirements. Multi-turn conversations also need to handle user follow-up questions on statistical indicators (e.g., 90% confidence interval), requiring the system to deeply understand and cite relevant statistical definitions. Queries about adverse events require keyword expansion to capture adverse reaction information expressed in different ways.
Configuration Settings
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
maxContext | 8 | Ensures enough historical conversation turns are retained in multi-turn dialogues to understand user intent and data relevance. |
Chunk size (Segment Length) | 1000 characters (characters) | Balances text block size and information density, adapting to the mix of paragraphs and tables in PDF documents. |
Recall count (Recall Count) | Top 5 entries (top 5) | Improves the efficiency and accuracy of retrieving relevant bioequivalence report segments from the knowledge base. |
Similarity threshold (Similarity Threshold) | 0.75 | Filters out document segments highly relevant to the user query, reducing interference from irrelevant information. |
Rerank result count (Reranked Return Count) | 3 | Reranks the recalled results to ensure the most relevant bioequivalence data or analysis conclusions are prioritized. |
Prompt Template (Prompt Template) | Includes keywords like "bioequivalence, AUC, Cmax, Tmax, 90% confidence interval" | Guides the model to focus on specific concepts and data types within the bioequivalence domain, enhancing the professionalism of responses. |
Three Common Mistakes
- "No context memory" in conversations often occurs when
maxContextis set too low, preventing the system from retaining a sufficiently long history of dialogue. - Empty data returned by online interfaces may be due to the document parser failing to correctly identify table structures in PDFs, leading to critical field extraction failures.
- The system may fail to respond to in-depth follow-up questions on specific statistical indicators (e.g., "geometric mean ratio") because the prompt template does not adequately cover these professional terms or the knowledge base lacks corresponding explanatory documents.
How to Confirm Correct Configuration
- Simulate multi-turn conversations to verify if the system correctly references bioequivalence parameters from previous turns.
- Upload a bioequivalence report PDF containing complex tables and check if the system accurately extracts and displays key plasma concentration data and statistical results from the tables.
- Test the system's understanding and explanation capabilities for bioequivalence-related professional terms (e.g., "reference preparation," "test preparation," "confidence interval") to ensure responses meet industry standards.
Note: The values provided are common starting points. Measure against your own samples for optimal performance.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.